Results 121 to 130 of about 33,657 (222)

Dengue vaccines: A new hope? [PDF]

Human Vaccines, 2009
Dengue infection is an important arboviral infection that has become a public health concern. Dengue vaccination is the expected primary prevention for this infection. However, dengue vaccine is not presently available. In this article, the author discusses and comments on the problem, hope and present status in dengue vaccine development.
openaire   +2 more sources

Estimating the public health importance of the CYD-tetravalent dengue vaccine : vaccine preventable disease incidence and numbers needed to vaccinate

, 2016
BACKGROUND: To evaluate the potential public health impact of the live attenuated tetravalent Sanofi Pasteur dengue vaccine (CYD-TDV) we analyzed data from the reported clinical trials to calculate vaccine preventable disease incidence (VPDI) and number ...
Wilder-Smith, Annelies, Wilder-Smith, Annelies,, Gessner, Bradford D, Gessner, Bradford D.   +3 more
core   +1 more source

Estudo in vitro das citocinas envolvidas na resposta inflamatória de macrófagos murinos à infecção pelo vírus da dengue. [PDF]

, 2012
TCC(graduação) - Universidade Federal de Santa Catarina. Centro de Ciências Biológicas. Biologia.A dengue é uma doença que tem como agente etiológico o Dengue virus (DENV), da família Flaviviridae, do gênero Flavivirus.
Souza, Ingrid Larissa Melo de
core  

Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice

, 2016
[[abstract]]We developed a novel platform to express high levels of recombinant lipoproteins with intrinsic adjuvant properties. Based on this technology, our group developed recombinant lipidated dengue envelope protein domain IIIs as vaccine candidates
Chiang, CY;Pan, CH;Chen, MY;Hsieh, CH;Tsai, JP;Liu, HH;Liu, SJ;Chong, P;Leng, CH;Chen, HW
core   +1 more source

A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity

, 2009
[[abstract]]A novel dengue vaccine candidate comprised of a consensus dengue virus envelope protein domain III (cED III) was developed to fight against dengue virus infection.
Leng, CH;Liu, SJ;Tsai, JP;Li, YS;Chen, MY;Liu, HH;Lien, SP;Yueh, A;Hsiao, KN;Lai, LW;Liu, FC;Chong, P;Chen, HW
core   +1 more source

[Dengue treatments and vaccines].

Medecine sciences : M/S
La dengue est une maladie virale transmise par les moustiques du genre Aedes, dont l’incidence et l’aire de répartition sont en constante augmentation depuis les dernières décennies. Causant des fièvres hémorragiques dans les cas graves, elle touche principalement les zones tropicales et subtropicales du globe, et menace de s’étendre à de nouvelles ...
Brézillon-Dubus, Lazare, Dupuis, Benjamin, Failloux, Anna-Bella   +2 more
openaire   +2 more sources

Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico´s Universal Vaccination Program

Salud Pública de México, 2016
Dengue is a major global public health problem affecting Latin America and Mexico Prevention and control measures, focusing on epidemiological surveillance and vector control, have been partially effective and costly, thus, the development of a vaccine ...
Mauricio Hernández-Ávila, José Ignacio Santos-Preciado   +1 more
doaj  

Proceedings of the inaugural symposium on dengue human challenge studies "Challenging the norm: Accelerating dengue countermeasures through human studies".

PLoS Neglected Tropical Diseases
On 12th June 2025, Duke-NUS Medical School, supported by the Global Dengue and Aedes-Transmitted Diseases Consortium (GDAC), hosted a one-day symposium in Singapore titled "Challenging the norm: Accelerating dengue countermeasures through human challenge
Shirin Kalimuddin, Adam T Waickman, Panisadee Avirutnan, Mohammad Shafiul Alam, Christopher Chiu, Barnaby E Young, Christopher W Woods, Petra C Fay, Sheila K Pakir, Jo-Anne Manski-Nankervis, Claus Bolte, Andrew Pengilley, Marco Cavaleri, John C W Lim, Stephen J Thomas, Albert I Ko, Eng Eong Ooi   +16 more
doaj   +1 more source

Using recombinant DNA technology for the development of live-attenuated dengue vaccines

, 2012
[[abstract]]Dramatic increases in dengue (DEN) incidence and disease severity have been reported, in great part due to the geographic expansion of . Aedes aegypti and . Aedes albopictus mosquitoes.
Lee, HC;Butler, M;Wu, SC
core   +1 more source

Dengue and Dengue Vaccines [PDF]

The Journal of Infectious Diseases, 2005
openaire   +1 more source